Introduction
Gastric cancer is one of the most common neoplasms and is a leading cause of death worldwide. 1 The overall survival rate for patients with gastric carcinoma has increased, as a result of improved detection of early cancers and wider implementation of radical surgery, but many patients die due to primary treatment failure or late-stage presentation. 2 Angiogenesis is an important aspect of tumour growth and progression, and is an essential step in the metastasis of cancer cells by vascular spread. 3 Vascular endothelial growth factor (VEGF) regulates the growth of endothelial cells, with VEGF-A being the most potent growth factor for angiogenesis. 3 The level of VEGF-A has been correlated with XD Zhou, HX Chen, RN Guan et al. pAkt and VEGF-A in gastric cancer angiogenesis tumour progression and poor survival in gastric cancer, 4, 5 and inhibition of angiogenesis is a potentially useful treatment approach.
The serine/threonine protein kinase B (Akt) is a downstream target of growth factor receptors via the phosphatidylinositol 3-kinase (PI3K) signalling pathway. 6 The PI3K/Akt signalling pathway regulates various cellular processes such as cell proliferation and survival, glucose utilization and inhibition of apoptosis. 6, 7 Akt was initially identified as an oncogene in mouse thymoma. 8 Activated (phosphorylated)
Akt (pAkt) is upregulated in various human tumours including colon, breast, pancreatic and gastric cancers. 9 -11 We have shown that Akt is involved in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. 12 In addition, PI3K/Akt signalling pathways are known to be important in angiogenesis.
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The relationship between Akt phosphorylation and VEGF-A and microvessel density in human gastric adenocarcinoma tissue is unclear, however.
The present study investigated the relationship between Akt phosphorylation and VEGF-A levels, in addition to microvessel density, in human gastric adenocarcinoma.
Materials and methods

STUDY POPULATION
Consecutive patients undergoing surgical resection for gastric adenocarcinoma at the Department of Gastroenterology, First Affiliated Hospital, Nanchang University, Nanchang, China, between May 2010 and June 2011, were recruited to the study. Patients who had received any chemo-, radio-or immunotherapy before surgery were excluded from the study. Tumours were staged and classified according to the tumour-node-metastasis (TNM) staging system and Lauren classification. 19 The study was carried out in accordance with the Declaration of Helsinki (2000) and was approved by the Ethics Committee of Nanchang University. Written informed consent was obtained from all participants.
SAMPLE COLLECTION
Samples of gastric adenocarcinoma and matched normal gastric mucosa (≥ 10 cm from the distal tumour margin) were collected from each patient and flash-frozen in liquid nitrogen. A portion of each sample was fixed in 10% buffered formalin, embedded in paraffin wax, and cut into 3-µm thick sections for histopathological analysis (hematoxylin and eosin staining) and immunohistochemical staining. A randomly selected subset of samples was used for Western blotting. All methods are described below.
WESTERN BLOTTING
Frozen gastric adenocarcinoma samples and their matched normal mucosa tissues were homogenized and lysed in buffer containing 40 mM Tris-HCl (pH 8.0), 120 mM sodium chloride, 0.5% nonyl phenoxypoly ethoxylethanol (NP-40), 1 mM phenylmethylsulphonyl fluoride, and 10 µg leupeptin per ml. Lysates were incubated on ice for 60 min then centrifuged at 9901 g for 20 min. For each sample, 50 g of protein was separated via 12% sodium dodecyl sulphatepolyacrylamide gel electrophoresis at 25°C and 200 V, then electrotransferred onto nitrocellulose membranes (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 25 V for 2 h. Membranes were blocked with 5% nonfat milk in TBST (10 
IMMUNOHISTOCHEMISTRY
Tissue sections were deparaffinized, rehydrated, heated in antigen retrieval buffer (DakoCytomation, Glostrup, Denmark) at 99°C for 20 min, and incubated in 3% hydrogen peroxide for 15 min to quench endogenous peroxidase. Sections were incubated in mouse monoclonal antihuman pAkt (Ser 473 ) (1 : 65 dilution; Cell Signaling Technology) or rabbit polyclonal antihuman VEGF-A (1 : 300 dilution; SC-152, Santa Cruz Biotechnology) at 4°C overnight. Negative controls were incubated with phosphate buffered saline (PBS; 0.01 M, pH 7.3) in place of primary antibody. Sections were washed three times with PBS (2 min each wash), incubated with biotinylated goat antimouse or goat antirabbit IgG (1 : 200 dilution, Santa Cruz Biotechnology) for 1 h at room temperature, and washed three times with PBS (2 min each wash). Immunoreactivity was detected using a streptavidin-peroxidase detection system (Santa Cruz Biotechnology) and visualized using 3,3′-diaminobenzidine (DAB) with haematoxylin as counterstain. Staining was classified as weak (light yellow), moderate (deep yellow) or strong (brown), and graded based on the percentage of cells stained with moderate or strong intensity: negative, < 5 % cells; moderate, 5 -50 %; high, > 50 %. Cases with moderate or high staining were considered positive. All immunostained slides were reviewed by the same pathologist, who was blinded to patient outcome.
QUANTIFICATION OF MICROVESSEL DENSITY
Tissue sections were deparaffinized, rehydrated and incubated in 3% hydrogen peroxide for 15 min to quench endogenous peroxidase. Slides were heated in a microwave oven for 10 min in 10 mM citrate buffer (pH 6.0), then incubated with rabbit monoclonal antihuman CD34 (1: 40 dilution; Maxim Biotech, San Francisco, CA, USA) overnight at 4°C. Slides were washed three times with 0.01 M PBS (pH 7.35) for 3 min each wash, incubated with peroxidaselabelled goat antirabbit IgG (1 : 200 dilution, DakoCytomation) for 10 min at 37°C and washed three times with PBS (3 min each wash). Immunostaining was visualized with DAB and sections were counterstained with haematoxylin.
Intratumoral microvessel density was determined as described. 20 In brief, the area of most intense neovascularization (preferably on the tumour margin) was selected by scanning on low magnification (× 10 -100). Only the vascularity of tumour areas considered to be viable (i.e. nonnecrotic) was taken into account. Individual 
Results
The study included 48 patients with gastric adenocarcinoma (28 males/20 females; mean age 58.5 ± 23.7 years, range 29 -80 years).
Western blotting for pAkt and Akt was performed on tissues from a selection of 20 patients. A representative Western blot is shown in Fig. 1 . Both pAkt and Akt were present at significantly higher levels in adenocarcinoma tissue than in matched normal tissue (P < 0.001 for both comparisons; Table 1 ).
Immunohistochemical staining for pAkt was located in the cytoplasm of tumour cells and normal gland epithelial cells (Figs 2A  and 2B ). Phosphorylated Akt staining was found in 67.7% (32/48) of gastric adenocarcinomas and 58.3% (28/48) of control tissue samples. In tumour tissue, positive pAkt staining was associated with poor differentiation (P = 0.016), late TNM stage (P = 0.014) and high microvessel density (P = 0.021) ( Table 2) .
Immunohistochemical staining for VEGF-A was visible in the cytoplasm in 52.1% (25/48) of tumour tissues (Fig. 2C ) and 18.8% (nine of 48) of normal gastric mucosa samples. Presence of VEGF-A was associated with late TNM stage (P = 0.029), lymph node metastasis (P = 0.011) and high microvessel density (P = 0.015) ( Table 2) . Positive VEGF-A staining was significantly associated with 
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positive pAkt staining (P = 0.012; Table 3 ).
The mean intratumoral microvessel density was 40.6 ± 15.1 vessels/0.723 mm 2 (range 14 -115 vessels/0.723 mm 2 ).
Intratumoral microvessels were found mainly at the periphery of the infiltrating tumour in nearly all instances (Fig. 2D ).
Discussion
A detailed understanding of the mechanisms underlying angiogenesis may be of therapeutic value for cancers that require neovascularization. Angiogenesis, as quantitated via microvessel density, plays significant clinical and pathological roles in cancer, 21, 22 and may be an independent, highly significant and accurate prognostic indicator. 20 Gastric cancer is a leading cause of death in Asia. 1 Tumour angiogenesis is considered to be the most important predictor of overall survival in gastric cancer, 23 but little is known about the molecular mechanism underlying gastric cancer angiogenesis. The angiogenic process has been shown to be triggered by several key tumour-derived growth factors, 24, 25 including VEGF-A and platelet-derived growth factor B. 24, 26, 27 Studies have found VEGF-A to be overexpressed in 40 -90% of gastric cancers, 5,28 -36 which is consistent with the 52.1% found in the present study. VEGF-A positivity has been correlated with increased microvessel density, vascular invasion, lymph node and distant metastases, and advanced tumour stage, suggesting that VEGF-A might be a useful biomarker of tumour aggressiveness. 28, 29 In the present study, VEGF-A positivity was correlated with lymph node metastasis, advanced tumour stage and increased microvessel density.
Upregulation of pAkt is closely related to poor prognosis in several tumour types, including colon, breast, pancreatic and gastric cancers. 9 -11 Levels of both Akt and pAkt were significantly higher in tumour tissue than normal tissue, in the present study. There was no correlation between presence of pAkt and age, gender, Lauren classification, tumour size or lymph node metastasis in the current study. Immunostaining for pAkt was significantly stronger in poorly differentiated and late TNM stage tumours, however. We have previously shown that Akt is important in the chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death, 12 but the role of Akt in the angiogenesis of gastric cancer remains unclear. • Received for publication 29 An important finding of the present study was the strong correlation between microvessel density and pAkt and VEGF-A in human gastric adenocarcinoma. The association between the PI3K/Akt signalling pathway and angiogenesis has been demonstrated in several in vitro and in vivo studies. 17, 18, 37, 38 An inhibitor of mammalian target of rapamycin (mTOR) induced downregulation of VEGF-A secretion via the PI3K/Akt/mTOR signalling pathway, eventually inhibiting neuroblastoma growth in vitro and in vivo. 37 The PI3K/Akt signalling pathway was also found to be required for hypoxia inducible factor (HIF)-1α and VEGF-A expression in 4-hydroxy oestradiol-induced carcinogenesis. 38 HIF-1α activated VEGFA gene expression and influenced both angiogenesis and tumour growth. The PI3K/Akt signalling pathway was also found to regulate HIF1A expression. 17, 18 An inhibitor of Akt phosphorylation significantly inhibited VEGF production in vitro, revealing the existence of a PI3K/Akt/VEGF signalling pathway. 39 Taken together, these studies suggest that the PI3K/Akt signalling pathway contributes to tumour angiogenesis via VEGF-A and HIF-1α.
In conclusion, the correlations between microvessel density and pAkt and VEGF-A positivity in the present study suggest that pAkt and VEGF-A are involved in angiogenesis of gastric adenocarcinoma. In addition, the relationship between pAkt and VEGF-A suggests that Akt activation contributes to angiogenesis via VEGF-A upregulation, indicating the presence of a PI3K/Akt/VEGF signalling pathway in gastric adenocarcinoma. 
